Astex Pharmaceuticals (ASTX) Release: Cancer Research Technology and Cancer Research UK Cambridge Research Institute Initiate AT13148 Clinical Trial to Treat Several Cancer Types
1/17/2013 9:16:44 AM
More...
|
Astex Pharmaceuticals (ASTX). Cancer Research Technology and Newcastle University Sign Strategic Drug Discovery Alliance
10/29/2012 8:47:10 AM
More...
|
Astex Pharmaceuticals (ASTX), Cancer Research Technology and The Institute of Cancer Research Announce Epigenetic Drug Discovery Collaboration
9/6/2012 9:26:36 AM
More...
|
Cytotoxic Warheads at Forefront of Cancer Research Technology, ADC Therapeutics' Anticancer Collaboration
7/6/2012 7:30:46 AM
More...
|
Cancer Research Technology Selects the Labcyte Inc. Access™ Laboratory Workstation to Prepare Assay-Ready Microplates for Cell-Based Screening
6/19/2012 10:50:19 AM
More...
|
BioInvent (BOVNF) and Cancer Research Technology Enter Oncology Collaboration
6/12/2012 10:10:03 AM
More...
|
Cancer Research Technology, EIF Create $80 Million Cancer Research Technology Pioneer Fund
3/29/2012 7:07:31 AM
More...
|
Scottish Scientists Trial Brain Cancer Vaccine, Cancer Research UK Cambridge Research Institute and Cancer Research Technology Study
10/19/2010 7:08:45 AM
More...
|
Scancell Signs Antibody Licence Agreement with Cancer Research Technology
8/10/2010 8:04:12 AM
More...
|
Cancer Research Technology Announces Partnership With Cephalon, Inc. (CEPH) To Co-Develop A New Class Of Anti-Cancer Drugs
3/23/2010 2:49:58 PM
More...
|
|